Facts Flashcards
DM treatment options with weight negative effect
metformin
GLP-1 (liraglutide, exenatide)
SGLT2 (-flozins)
Which DM medication should be avoided with history of genital mycotic infections
SGLT2 (-glflozin)’s
colon cancer screening in UC
start 8-10 years after UC diagnosis and repeat every 1-2 years
treatment of pulmonary arterial HTN
If + response to vasoactivity test –> CCB FIRST
no symptoms at rest, only activity – then start with oral meds
(PDE-5 inhibitors = sildenafil, viagra) or
(enothelian receptor antag = bosentan, ambristan)
treatment of rising PSA after prostate cancer in past
radiation and leuprolide (androgen deprivation)
pyoderma gangrenosum
non healing ulcer, culture neg
assoc with UC/ IBD
tx: prednisolone, cyclosporine
goal BP for intracerebral hemorrhage?
<140 systolic
ethylene glycol overdose clinical features and tx
CNS depression
inc anion gap metabolic acidosis
inc plasma osmolar gap (>10 difference bw measured and calculated serum osm)
renal failure
tx: fomepazole, HD IV bicarb (if pH <7.3)
DM medications to lower cardiac risk
liraglutide
empagliflozin (dc all cause mortality, death by CVD and HF hospitalizations)
BMI cut off for bariatric surg
> 40 or >35 with obesity related comorbidities
lower incidence of statin induced myopathy with…
pravastatin, rosuvastatin
criteria for lung transplant referral
FEV1 <25%, PaO2 <60, CO2 >50
hidradenitis suppurativa tx
clindamycin-rifampin
infliximab
surgical excision
normal ABI
PAD ABI
nl: 0.9 -1.4
PAD: <0.9
ischemic rest pain < 0.4
if borderline nl and symptomatic–do EXERCISE abi
if > 1.4 it indicates the presence of calcified, noncompressible arteries in the lower extremities and is considered uninterpretable.— do toe brachial index instead
treatment of glioblastoma (IV)
surgical resection
followed by chemo (Temozolomide) + RT
acute Wegners treatment to induce remission
steroids and rituxmab or cyclophosphamide
DEXA score cut offs
osteoporosis < -2.5
osteopenia (-1 to -2.5
normal -0.9 to 1+
Indications for antiresporptive treatment (ex: bisphosphonates, denosumab, raloxifene, teriparatide)
osteoporosis
osteopenia with FRAX > 20% major and >3% hip
fragility fracture
vertebral or hip fracture
moderate or high 10-year risk for a major osteoporotic fracture taking at least 2.5 mg of prednisone daily for 3 months
risk of DKA with which diabetes med
SGLT-2 inhibitors (-flozins)
** DKA with normal glucose
anti-HTN to lower serum urate
losartan
HCTZ and salicylates elevate it and predisposes to gout
acute gout flare tx
NSAIDS (CI in PUD, CKD, HF, old, post op)
colchicine (CI in kidney failure)
glucocorticoids (oral vis intra-articular)
** do not change dose of allopurinol during acute flare
indications for long term urate lowering therapy
2 attacks of gout
1 attack with CKD
uric acid nephrolithiasis
visible tophi
tx options: allopurinol, febuxostat (for non tolerance allopurinol), IV pegloticase (severe refractory)
**give NSAID/Colchine with when initiation and continue flare prophylaxis if active disease or tophi for 3-6 months
tx for refractory gout
IV peglocticase
tx of status epilecpticus
IV lorazepam then phenytoin or fosphyenytonin (not keppra)